Bausch Health Companies INC Form 4 insider transactions

Christian A. Garcia, a director at Bausch Health Companies Inc., was granted 35,360 restricted share units valued at $250,000 on May 17, 2024.

Director Frank D. Lee acquired 35,360 common shares of Bausch Health Companies Inc. through a restricted share unit (RSU) grant on May 17, 2024.

Director Amy Wechsler acquired 35,360 common shares of Bausch Health Companies Inc. through restricted share units (RSUs) granted on May 17, 2024.

Director Robert N. Power acquired 35,360 common shares of Bausch Health Companies Inc. through a restricted share unit (RSU) grant on May 17, 2024.

Director John Paulson received 35,360 restricted share units from Bausch Health Companies Inc. on May 17, 2024.

Richard Mulligan, a director at Bausch Health Companies Inc., amended a previous filing to report the acquisition of 35,360 common shares through a restricted stock unit (RSU) award.

Director Steven D. Miller reports acquisition of 35,360 restricted share units (RSUs) and disposition of 10,000 common shares held indirectly through an IRA.

Director Sarah B. Kavanagh of Bausch Health Companies Inc. received 35,360 restricted share units (RSUs) valued at $250,000 on May 17, 2024, and disposed of 182,012 common shares.

Director Brett Icahn reports acquisition of restricted share units and disposal of common shares of Bausch Health Companies Inc.

Director John Paulson reports the acquisition of 5,890 common shares of Bausch Health Companies Inc. at a price of $10.61 per share on March 29, 2024.

Director Brett Icahn reports acquiring 3,122 common shares of Bausch Health Companies Inc. at $10.61 per share on March 29, 2024.

Director Russel C. Robertson acquired 2,945 common shares of Bausch Health Companies Inc. at a price of $10.61 on March 29, 2024.

Director Amy Wechsler reported acquiring 647 common shares of Bausch Health Companies Inc. at a price of $10.61 on March 29, 2024.

John S. Barresi, SVP, Controller & CAO of Bausch Health Companies Inc., reports acquisition and disposal of common shares and restricted share units.

Bausch Health Companies Inc. CEO Thomas Appio acquired shares through restricted share units and subsequently disposed of shares to cover tax withholding obligations.

Seana Carson, EVP and General Counsel of Bausch Health Companies Inc., reports acquisition of shares through restricted share units and subsequent disposals to cover tax obligations and sales under a 10b5-1 plan.